Anaergia (ANRG) Q4 2023 earnings summary

Executive summary

• 2023 marked a year of transition, with restructuring and a strategic review process underway to improve operations and financial health.

• Key developments included the closing of two tranches of a $40.8 million strategic investment by Marny Investissement SA.

• Leadership changes included the resignation of the CFO and appointment of an interim CFO.

Financial highlights

• Q4 2023 revenue was $33.4 million, down from $41.0 million in Q4 2022; full-year revenue fell 9.2% to $147.0 million.

• Q4 gross profit rose 84.4% to $3.5 million, but full-year gross profit dropped 26.1% to $19.7 million.

• Q4 net loss was $34.1 million, improved from $41.3 million loss in Q4 2022; full-year net loss widened to $192.8 million from $79.0 million.

• Adjusted EBITDA for Q4 improved to $(7.7) million from $(18.9) million; full-year Adjusted EBITDA declined to $(34.9) million from $(26.2) million.

Key financial ratios and metrics

• Q4 gross margin increased to 10.5% from 4.6% year-over-year; full-year gross margin decreased to 13.4% from 16.5%.

• Total assets at year-end were $278.7 million, down from $931.8 million; equity fell to $73.6 million from $336.0 million.